Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NECITUMUMAB vs NEOMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NECITUMUMAB vs NEOMYCIN: Safety Overview

Metric NECITUMUMAB NEOMYCIN
Total FAERS Reports 367 1,515
Deaths Reported 69 724
Death Rate 18.8% 47.8%
Hospitalizations 131 801
Average Patient Age 65.4 yrs 50.7 yrs
% Female Patients 20.0% 92.7%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Eli Lilly and Company Target Corporation
Route INTRAVENOUS TOPICAL
Marketing Status Prescription Discontinued